GetTopicDetailResponse(id=2b111e82a2, topicName=ABT-199, introduction=ABT-199, content=null, image=null, comments=1, allHits=752, url=https://h5.medsci.cn/topic?id=1782, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=15448, tagList=[TagDto(tagId=15448, tagName=ABT-199)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1981780, encodeId=61cb1981e80d5, content=<a href='/topic/show?id=2b111e82a2' target=_blank style='color:#2F92EE;'>#ABT-199#</a>, objectTitle=Leukemia：選擇性Bcl-2抑制劑ABT-199臨床試驗(yàn)證明對(duì)白血病療效良好, objectType=article, longId=27984, objectId=83392e98476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83392e98476, replyNumber=0, likeNumber=100, createdTime=2014-08-15, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83392e98476, moduleTitle=Leukemia：選擇性Bcl-2抑制劑ABT-199臨床試驗(yàn)證明對(duì)白血病療效良好, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=83392e98476)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
